Sonoma Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $162K, a 53.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $162K -$188K -53.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $216K -$138K -39% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $286K -$132K -31.6% Mar 31, 2024 10-Q 2024-11-07
Q4 2023 $341K -$130K -27.6% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $350K -$180K -34% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $354K -$124K -25.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $418K -$141K -25.2% Mar 31, 2023 10-K 2024-06-17
Q4 2022 $471K -$152K -24.4% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $530K -$170K -24.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $478K -$244K -33.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $559K -$210K -27.3% Mar 31, 2022 10-K 2023-06-21
Q4 2021 $623K -$48K -7.15% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $700K +$66K +10.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $722K +$379K +110% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $769K +$410K +114% Mar 31, 2021 10-K 2022-07-13
Q4 2020 $671K -$386K -36.5% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $634K -$544K -46.2% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $343K -$973K -73.9% Jun 30, 2020 10-Q/A 2020-11-17
Q1 2020 $359K +$359K Mar 31, 2020 10-K 2021-07-14
Q4 2019 $1.06M Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $1.18M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $1.32M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $0 Mar 31, 2019 10-K 2020-07-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.